net dbt
increas po stabl outlook
limit upsid leav us neutral
excit growth driver appear alreadi price
follow recent acceler group multipl potenti sustain growth
product opportun dentspli sirona primescan upgrad cycl
increas price object reiter neutral rate
due limit upsid current level recent quarter saw softer na
dental consum growth still gener above-consensu ep due cost
manag part compani restructur plan well mix shift privat
label technolog sale addit hsic guidanc
contain neg surpris rel growth expect likelihood limit
near-term downsid despit posit trend end-market demand north
american dental consum particular remain tepid think growth
benefit primescan upgrad cycl specialty/technolog launch
see enough drive meaning stock upsid henc neutral
rate new po ev/ebitda
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
one world largest distributor
dental medic product also provid
solut broad rang financi servic
primarili fragment custom base
compani headquart melvil new york
oper countri
remain market leader experienc
growth headwind still trade premium
valuat peer group compani
share gainer across key market dental
busi also see acceler contribut
equip side transit
trend still remain difficult predict na
medic see moder growth due multi-
price object base ev/ebitda previous
close compani histor trade rang account less
visibl growth/margin opportun off-set demographically-posit end market
increment contribut increas technolog revenu
upsid risk po stronger expect dental consumable/equip sale
either new relationship sirona share win faster uptak
one jv cost ration downsid risk wors expect share gain
sirona-rel revenu increment pressur slowdown dental consum
growth new competit amazon creat signific growth margin
pressur segment
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
